Clinical Trial Update: CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a CD8-depleted, non-engrafting, HLA-mismatched unrelated donor infusion in patients with myelodysplastic syndromes and secon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CD8-depleted, non-engrafting, HLA-mismatched unrelated donor infusion

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-22